Viscosupplementation Market
According to Intent Market Research, the Viscosupplementation Market is expected to grow from USD 4.8 billion in 2024-e at a CAGR of 23.4% to touch USD 17.0 billion by 2030. The Viscosupplementation Market is dominated by key players such as Zimmer Biomet, Sanofi S.A., Johnson & Johnson, AbbVie Inc., Ferring Pharmaceuticals, Medtronic PLC, Smith & Nephew PLC, Mylan N.V., Eppendorf AG, B. Braun Melsungen AG, Regen Lab SA, OrthogenRx, Inc., Anika Therapeutics, Inc.